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ABSTRACT: By use of oligonucleotide-directed, site-specific mutagenesis, Pro327 in the lac permease of 
Escherichia coli has been replaced with Ala, Gly, or Leu. Permease with Ala at  position 327 catalyzes 
lactose/H+ symport in a manner indistinguishable from wild-type permease. Permease with GIy at position 
327, on the other hand, exhibits about one-tenth the activity of wild-type permease but catalyzes lactose 
accumulation to essentially the same steady-state level as wild-type permease. Finally, permease with Leu 
at position 327 is completely inactive. The results demonstrate that there is no relationship between permease 
activity and the helix-breaking (Pro and Gly) or helix-making (Ala and Leu) properties of the residue at  
position 327. It is suggested that it is primarily a chemical property of the side chain at  position 327 (Le., 
bulk, hydropathy, and/or ability to hydrogen bond) that is critical for activity and that neither cis/trans 
isomerization of Pro327 nor the presence of a kink at  this position is important. 
z e  lac permease of Escherichia coli is a hydrophobic 
transmembrane protein that catalyzes the coupled translocation 
of a single @-galactoside molecule with a single H+ [i.e., lac- 
tose/H+ symport; cf. Kaback (1986a,b) for recent reviews]. 
The permease is encoded by the lac Y gene, the second 
structural gene in the lac operon, and it has been purified to 
homogeneity, reconstituted into proteoliposomes, and dem- 
onstrated to be solely responsible for o-galactoside transport 
in E.  coli. In addition, recent studies (Costello et al., 1987) 
indicate that lac permease is completely functional as a mo- 
nomer. 
Secondary structure models for the permease based on the 
hydropathy of the amino acid sequence suggest that the po- 
lypeptide is organized into 12-14 hydrophobic a-helical do- 
mains that traverse the membrane in zig-zag fashion, con- 
nected by more hydrophilic, charged regions (Foster et al., 
1983; Bieseler et al., 1985; Wright et al., 1985; Vogel et al., 
1985). Evidence supporting certain general aspects of the 
models has been obtained from circular dichroic (Foster et al., 
1983), laser Raman (Vogel et al., 1985), and Fourier transform 
infrared (P. D. Roepe, K. J. Rothschild, and H. R. Kaback, 
unpublished information) spectroscopy, from limited proteo- 
lysis studies (Goldkorn et al., 1983; Stochaj et al., 1986), and 
from binding studies with monoclonal (Carrasco et al., 1982, 
1984a; Herzlinger et al., 1984, 1985) and site-directed poly- 
clonal antibodies (Seckler et al., 1983; Carrasco et al., 1984k 
Danho et al., 1985; Seckler et al., 1986). 
By use of oligonucleotide-directed, site-specific mutagenesis 
(Zoller & Smith, 1983; Sarkar et al., 1986), it has been 
demonstrated that Arg302 (putative helix IX), His322 (pu- 
tative helix X), and Glu325 (putative helix X) are critical for 
lactose/H+ symport, while a number of other mutations have 
no significant effect on permease activity (Piittner et al., 1986; 
Carrasco et al., 1986; Menick et al., 1987a,b). Moreover, 
molecular modeling and other studies [cf. Menick et al. 
(1987b)l are consistent with the notion that the three residues 
may be sufficiently close to form a catalytic triad, and it has 
been suggested that they may function as components of a 
charge relay [cf. Kaback (1987, 1988) for reviews]. 
In view of the importance of Arg302/His322/Glu325 for 
permease activity and the unique properties of proline residues 
with regard to protein folding, we have now focused on Pro327 
in putative helix X. 
EXPERIMENTAL PROCEDURES 
Materials 
[ I-14C]Lactose was synthesized by Yu-Ying Liu under the 
direction of Arnold Liebman (Isotope Synthesis Group, 
Hoffmann-La Roche, Inc.) [ '251]Protein A was purchased 
from Amersham/Searle and isopropyl 1 -thio-P-D-galacto- 
pyranoside from Bethesda Research Laboratories. All other 
materials were of reagent grade and were obtained from 
commercial sources as described (Sarkar et al., 1986). 
Methods 
Bacterial Strains. The following strains of E.  coli K- 12 were 
used: JM101, supE, thi, A(1ac-proAB), [F' traD36, proA+B+, 
lacIqZ~L441SJ (Yanish-Perron et al., 1985); BMH71-18 mutL, 
A ( lac-pro) , supE, th i/proA+ B+, IacPZ AMI 5 /  Mu t L : : Tn I 0 
(Kramer et al., 1984); T206 [lacZ+@Z-T(A),  rpsL, met-, 
thr-, recA, hsdM, hsdR/F', lacP@Zul'*( F A + ) ]  harboring 
plasmid pGM21 [ lacA( l )O+P+A(Z)PA(A) ,  ret'] (Teather 
et al., 1980); T184 (T206 cured of plasmid pGM21) (Teather 
et al., 1980); HB101, hsdS2O ( f B ,  m s ) ,  recAl3, ara-14, 
proA2, lacY1, galK2, rpsL20(Smr), xyl-5, mtl-1, supE44, 
A-/F (Boyer & Roulland-Dussoix, 1969). 
Oligonucleotide-Directed, Site-Specific Mutagenesis. 
Site-directed mutagenesis using M13mp19 as a cloning vector 
was performed essentially as described (Sarkar et al., 1986) 
or with given modifications. The sequences of the mutagenic 
primers used to change codon 327 for Pro (CCG) into codons 
for Gly (GGG), Ala (GCG), or Leu (CTG) are given in Table 
I. Mismatch repair was minimized by transfecting the het- 
eroduplex DNA into the mutator strain E. coli BMH71-18 
mutL (Kramer et al., 1984). Mutations were verified by 
dideoxynucleotide sequencing (Sanger et al., 1977; Sanger & 
Coulson, 1978) with a synthetic primer complementary to the 
region of lac Y 50-100 nucleotides downstream from codon 
327 [cf. Padan et al., (1985)J. In addition, the entire l a c y  
genes in MI  3mp19 single-stranded (ss)~ DNA encoding 
P327G and P327L were sequenced by using six synthetic 
oligonucleotide primers complementary to appropriate regions 
* To whom correspondence should be addressed. 
~ ~ 
~~ ~ 
' Abbreviations: ss, single stranded; RF, replicative form; EMB, eosin 
methylene blue. 
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Table I: DNA Sequence Analysis of Codon 327 Mutants of the lac Y Gene 
plasmid mutagenic primer DNA seauence change amino acid seauence change 
pP327A 3’-AAACTTCAT=AAGGACGAC-5’ CCG - GCG Pro - Ala 
pP327G 3’-AAACTTCATaAAGGACGACCAC-5’ CCG - GGG Pro - Gly 
pP327L 3’AAACTTCAT=AAGGACGAC-5‘ CCG - CTG Pro - Leu 
of lac Y. Finally, all three mutations were confirmed by 
sequencing the region around codon 327 in plasmids pP327A, 
pP327G, and pP327L. With the exception of the base changes 
described, each gene has a nucleotide sequence identical with 
that reported by Biichel et al. (1980). 
Cell Growth. E .  coli T184 bearing a given plasmid was 
grown and induced with isopropyl 1 -thio-@+galactopyranoside 
as described (Teather et al., 1980). 
Transport Assays. Transport of [ l-14C]lactose was assayed 
by rapid filtration as described (Trumble et al., 1984). The 
reaction mixtures contained cells at a concentration of 0.7 mg 
of protein/mL in 0.1 M potassium phosphate (pH 7.9, 10 mM 
magnesium sulfate, and 0.35 mM [ l-14C]lactose. 
Zmmunoblots. In order to assess the amount of permease 
in the membrane, E. coli T184 harboring a given plasmid was 
resuspended in distilled water to a protein concentration of 
7 mg/mL, and aliquots (3 pL) were spotted in triplicate on 
a nitrocellulose filter (Schleicher & Schuell, BA 85/20). The 
cells were lysed by placing the filter in contact with Whatman 
filter paper soaked in 0.45 N NaOH containing 1% sodium 
dodecyl sulfate and incubating for 10 min at room tempera- 
ture. The nitrocellulose was neutralized by placing it in contact 
with filter paper soaked in 1.0 M Tris-HC1 (pH 7.4), followed 
by shaking for 20 min at room temperature in 10 mM 
Tris.HC1/150 mM NaCl (pH 7.4) (TBS) containing 0.1% 
Tween 20. Nonspecific binding sites were blocked by shaking 
for 1 h in 15 mL of TBS containing 5% bovine serum albumin 
(BSA) and 0.2% Nonidet P40. Four hundred microliters of 
ascites fluid containing monoclonal antibody (Mab) 4A10R 
(Herzlinger et al., 1984) was added to the filter, and incubation 
was carried out overnight at room temperature. The filter was 
then soaked sequentially in each of the following solutions for 
20 min: (i) TBS/5% BSA/O.2% Nonidet P40; (ii) TBS/O.2% 
Nonidet P40; and (iii) TBS/O.l% Tween 20. The filter was 
blocked again as described above with TBS/BSA/Nonidet P40 
and incubated for 2 h with [1251]protein A (25 pL of 3.7 
MBq/mL; 1480 MBq/mg), followed by the same sequential 
washings as described after incubation with Mab 4A10R. 
Finally, the filter was air-dried, and the spots were excised and 
assayed for radioactivity in a y counter. Control experiments 
demonstrated that the amount of cells spotted on the filter was 
within the linear range of the response curve. Cells harboring 
pACYC, which has no lac Y insert, were used as negative 
controls and yielded approximately 4% of the signal obtained 
with cells harboring pGM21. 
RESULTS 
Verification of Mutations by DNA Sequencing. The lac 
Y gene in each plasmid used was cloned initially from pGM21 
into M13mp19 replicative form (RF) DNA, and ss phage 
DNA was isolated and used as template for site-directed 
mutagenesis. Subsequently, ss phage DNA containing mu- 
tated lac Y was isolated and sequenced (Sanger et al., 1977; 
Sanger & Coulson, 1978) with an appropriate primer com- 
plementary to the region of lac Y 50-150 bases downstream 
from codon 327. The sequence analyses summarized in Table 
I demonstrate that the mutated lac Y genes contain changes 
in codon 327 such that Pro is replaced with Gly, Ala, or Leu 
as indicated. In addition, the entire nucleotide sequence of 
~ ~ p G y 1 ,  pP327A 
pP327G / 
Time ( m i d  
FIGURE 1: ~14C1Lactose uDtake in E .  coli strain T184 bearing the 
plasmid pGhM2i (O) ,  pP3i7A (0), pP327G (A), pP327L (3, or 
pACYC (m). 
the lac Y genes encoding the P327G and P327L mutations was 
determined by using six synthetic sequencing primers. With 
the exception of the alterations given in Table I, the remainder 
of the sequences was identical with that reported by Buchel 
et al. (1980). 
Colony Morphology on Lactose/Eosin Methylene Blue 
(EMB). The lac Yinsert was restricted from M13mp19 RF 
DNA with EcoRI and ligated into the EcoRI site of pACYC. 
The resulting plasmids pP327A, pP327G, and pP327L were 
used to transform the cryptic strain E. coli HBlOl ( Z ’ Y ) ,  
and the transformed cells were grown on EMB plates con- 
taining 25 mM lactose (Padan et al., 1985). HBlOl harboring 
pGM21, which encodes wild-type permease, grows as dark red 
colonies, indicative of lactose transport and subsequent me- 
tabolism at a high rate. In contrast, HBlOl containing PA- 
CYC, the vector without a lac Y insert, grows as white colo- 
nies. HB101/pP327A is indistinguishable from HB101/ 
pGM21, while HB101/pP327L is indistinguishable from 
HBlOl/pACYC. HBlOl/pP327G exhibits intermediate 
behavior; the colonies become red, but at a slower rate than 
observed with either HBlOl/pGM21 or HB101/pP327A. 
Qualitatively, therefore, it appears that P327A permease 
transports lactose like wild-type permease, while P327G 
permease is significantly less active and P327L permease is 
inactive. 
Lactose Transport. The qualitative conclusions suggested 
by colony morphology are confirmed by transport studies with 
E.  coli T184 (2-T) transformed with each plasmid (Figure 
1). The initial rate of lactose transport and the steady-state 
level of accumulation are identical within experimental error 
in T184/pGM21 and T184/pP327A. On the other hand, the 
initial rate of transport in T184/pP327G is approximately 10% 
of that observed in T184/pGM21 or T184/pP327A, but the 
steady-state level of accumulation approaches that observed 
in the latter strains. Finally, T184/pP327L is completely 
A C C E L E R A T E D  P U B L I C A T I O N S  
Table 11: Specific Activity of the Pro327 Mutants and a-Helical 
Propensities of the Residues Involved 
V O L .  2 7 ,  N O .  2 2 ,  1 9 8 8  8309 
intial rate 
of uptake" specific a-helical 
(nmol expression activity" propen- 
mutant min-' mg-') (% w-t) (% w-t) sityb 
Pro327 (w-t) 25.0 100 100 0.59 
Ala327 25.4 105 97 1.45 
Gly327 2.8 97 12 0.53 
Leu327 0 72 0 1.34 
"The intial rate of uptake and the specific activity apply to the con- 
ditions in Figure 1. w-t = wild type. bThe a-helical propensities are 
taken from Chou and Fasman (1974). The scale ranges from 0.53 for 
Glv to 1.53 for Glu. 
devoid of activity, as judged by the observation that lactose 
transport in this strain is identical with that observed in 
T184/pACYC. 
The specific activity of the strains described was estimated 
from the rate of transport at 30 s and the amount of permease 
present in the membrane, as determined by immunoblot 
analyses with Mab 4A10R and [1251]protein A (Table 11). 
P327A permease has essentially the same activity as wild-type 
permease, P327G permease exhibits about 12% of wild-type 
activity, and P327L has no activity. 
DISCUSSION 
The side chain of a Pro residue curls back in covalent linkage 
to the nitrogen of the peptide bond forming a pyrrolidine ring, 
which makes both the peptide bond and the side chain rigid. 
These unique features of Pro and the prolyl peptide bond 
account for certain aspects of polypeptide folding at positions 
where Pro is found. 
Generally, the partial double-bond character of the peptide 
bond inhibits free rotation about the bond, and steric hindrance 
caused by the two neighboring side chains favors the trans over 
the cis configuration. Therefore, the peptide bond, which is 
synthesized stereospecifically in the trans configuration at the 
ribosome, is also found to be trans in the structures of folded 
proteins. Pro affects cis/trans configuration by two means. 
First, the energy barrier between cis and trans configurations 
is lowered due to ring puckering. Second, the steric advantage 
of trans over cis is reduced considerably, since the hydrogen 
atom bonded to the peptide nitrogen is replaced with the side 
chain of Pro. Consistent with these considerations are the 
finding of cis configurations on the N-terminal side of Pro in 
a number of globular proteins (Schulz & Schirmer, 1978) and 
the role that cis/trans isomerization plays in protein folding 
(Brandts et al., 1975; Kelley & Richards, 1987). It is also 
noteworthy that cis/trans isomerization of the peptide bond 
preceding Pro has been proposed to play a role in the mech- 
anism of active transport (Dunker, 1982; Brandl & Deber, 
1986). 
In addition, the ring formed by C,, the N of the peptide 
bond, and the side chain of Pro severely restricts the dihedral 
angle between C, and N, thereby limiting the degree of 
freedom for the folding of the polypeptide backbone. Using 
data based on globular proteins of known stucture, Chou and 
Fasman (1974) demonstrated initially that Pro is found with 
high frequency in @-turns and in low frequency in a-helices 
or @-sheets. Similar statistics do not exist for membrane 
proteins because of insufficient structural data, and secondary 
structure predictions for the hydrophobic proteins are based 
primarily on hydropathy analysis of amino acid sequence (Kyte 
& Doolittle, 1982) and on inferences derived from globular 
proteins. For many membrane proteins, lac permease in 
particular (Foster et al., 1983), the hydropathy profiles exhibit 
multiple stretches of hydrophobic residues long enough to 
traverse the membrane in a-helical conformation separated 
by shorter, hydrophilic regions. In many instances, however, 
the putative helical domains contain Pro residues, in apparent 
contradiction to the statistical analyses of globular proteins. 
Thus, it has been suggested that structural discontinuities (Le., 
kinks) may be present in the transmembrane, a-helical do- 
mains at Pro residues. 
The first aim of this study was to determine whether or not 
cis/trans isomerization of the peptide bond preceding Pro327 
in the lac permease might play a role in the transport mech- 
anism (Dunker, 1982; Brandl & Deber, 1986). Since isom- 
erization is a unique property of Pro residues, any replacement 
for Pro327 should yield inactive permease, which is clearly not 
the case. Thus, cis/trans isomerization of the peptide bond 
between Val326 and Pro327 cannot be important for lac- 
tose/H+ symport. 
The second objective was to investigate the importance of 
a possible structural disctontinuity at position 327 of the 
permease by replacing the Pro residue at this position in the 
wild-type molecule with Gly, another "helix-breaking" residue, 
and Ala or Leu, two "helix-making" residues (Chou & Fas- 
man, 1974; cf. Table 11). The results demonstrate clearly that 
there is no correlation between permease activity and tendency 
of the amino acid residue at position 327 to make or break 
helices. Thus, P327A permease catalyzes lactose/H+ symport 
as well as wild-type permease despite the contention that Ala 
is an amino acid with a high probability of being in a helix. 
In contrast, replacement of Pro327 with Gly, a residue even 
less likely than Pro to be found in a-helices, yields permease 
with about 10% of wild-type permease activity. Finally, re- 
placement of Pro327 with Leu, another amino acid with a 
strong tendency to be found in a-helices, completely inactivates 
the permease. 
Although it is impossible to provide a definitive interpre- 
tation for the role of Pro327 without a high-resolution structure 
of the permease, it is apparent that the effects of the re- 
placements described are due to specific chemical properties 
of the side chains (i.e., bulk, hydropathy, and/or ability to 
hydrogen bond). In addition, the following possibilities merit 
consideration. (i) Pro327 may be in an a-helical domain 
(putative helix X), causing little or no structural discontinuity 
[cf. Menick et al. (1987b)], a conclusion consistent with the 
extremely high helical content of the permease and with the 
experiments of Bieseler et al. (1985). (ii) Pro327 may be in 
an a-helical domain and cause a structural discontinuity that 
is not important for activity. (iii) Pro327 may be in a non- 
helical domain. In any case, the results highlight one of the 
caveates inherent in applying principles derived from statistical 
studies on globular proteins to hydrophobic membrane proteins. 
REFERENCES 
Bieseler, B., Prinz, H., & Beyreuther, K. (1985) Ann. N.Y.  
Acad. Sci. 456, 309. 
Boyer, H. W., & Roulland-Dussoix, D. (1969) J .  Mol. Biol. 
41,  459. 
Brandl, C. J., & Deber, C. M. (1986) Proc. Natl. Acad. Sci. 
U.S.A. 83, 917. 
Brandts, J. F., Halvorson, H. R., & Brennan, M. (1975) 
Biochemistry 14, 4953. 
Buchel, D. E., Groneborn, B., & Muller-Hill, B. (1980) Nature 
(London) 283, 541. 
Carrasco, N., Tahara, S. M., Patel, L., Goldkorn, T., & Ka- 
back, H. R. (1982) Proc. Natl. Acad. Sci. U.S.A. 79,6894. 
Carrasco, N., Viitanen, P., Herzlinger, D., & Kaback, H. R. 
( 1  984a) Biochemistry 23, 368 1. 
8310 B I O C H E M I S T R Y  
Carrasco, N., Herzlinger, D., Mitchell, R., DeChiara, S. ,  
Danho, W., Gabriel, T. F., & Kaback, H. R. (1984b) Proc. 
Natl. Acad. Sci. U.S.A. 81, 4672. 
Carrasco, N., Antes, M. L., Poonian, M. S. ,  & Kaback, H. 
R. (1986) Biochemistry 25, 4486. 
Chou, P. Y., & Fasman, G. D. (1974) Biochemistry 13, 222. 
Costello, M. J., Escaig, J., Matsushita, K., Viitanen, P. V., 
Menick, D. R., & Kaback, H. R. (1987) J. Biol. Chem. 262, 
17072. 
Danho, W., Makofske, R., Humiec, F., Gabriel, T. F., Car- 
rasco, N., & Kaback, H. R. (1985) Pept.: Struct. Funct., 
Proc. Am.  Pept. Symp. 9th, 59. 
Dunker, A. K. (1982) J.  Theor. Biol. 97, 95. 
Foster, D. L., Boublik, M., & Kaback, H.  R. (1983) J. Biol. 
Chem. 258, 31. 
Goldkorn, T., Rimon, G., & Kaback, H. R. (1983) Proc. Natl. 
Acad. Sci. U.S.A. 80, 3322. 
Herzlinger, D., Viitanen, P., Carrasco, N., & Kaback, H. R. 
(1984) Biochemistry 23, 3688. 
Herzlinger, D., Carrasco, N., & Kaback, H. R. (1985) Bio- 
chemistry 24, 22 1. 
Kaback, H. R. (1986a) in Physiology of Membrane Disorders 
(Andreoli, T. E., Hoffman, J. F., Fanestil, D. D., & Schultz, 
S .  G., Eds.) pp 387-408, Plenum, New York. 
Kaback, H. R. (1 986b) Annu. Rev. Biophys. Biophys. Chem. 
15, 279. 
Kaback, H. R. (1987) Biochemistry 26, 2071. 
Kaback, H. R. (1988) Annu. Rev. Physiol. 50, 243. 
Kelley, R. F., & Richards, F. M. (1987) Biochemistry 26, 
Kramer, B., Kramer, W., & Fritz, H. J. (1984) Cell (Cam- 
Kyte, J., & Doolittle, R. F. (1982) J. Mol. Biol. 157, 105. 
Menick, D. R., Lee, J. A., Brooker, R. J., Wilson, T. H., & 
Menick, D. R., Carrasco, N., Antes, L. M., Patel, L., & 
6765. 
bridge, Mass.) 38, 873. 
Kaback, H. R. (1987a) Biochemistry 26, 1132. 
Kaback, H. R. (1987b) Biochemistry 26, 6638. 
A C C E L E R A T E D  P U B L I C A T I O N S  
Padan, E., Sarkar, H. K., Viitanen, P., Poonian, M. S., & 
Kaback, H. R. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 
6765. 
Piittner, I .  B., & Kaback, H. R. (1988) Proc. Natl. Acad. Sci. 
U.S.A. 85, 1467. 
Piittner, I. B., Sarkar, H. K., Poonian, M. S. ,  & Kaback, H. 
R. (1986) Biochemistry 25, 4483. 
Sanger, F., & Coulson, A. R. (1978) FEBS Lett. 87, 107. 
Sanger, F., Nicklen, S. ,  & Coulson, A. R. (1 977) Proc. Natl. 
Acad. Sci. U.S.A. 74, 5463. 
Sarkar, H. K., Viitanen, P. V., Padan, E., Trumble, W. R., 
Poonian, M. S . ,  McComas, W., & Kaback, H. R. (1986) 
Methods Enzymol. 125, 214. 
Schulz, G. E., & Schirmer, R. H. (1979) in Principles of 
Protein Structure, Chapter 2, pp 17-26, Springer Verlag, 
Heidelberg and New York. 
Seckler, R., Wright, J. K., & Overath, P. (1983) J .  Biol. 
Chem. 258, 10817. 
Seckler, R., Moroy, T., Wright, J. K., & Overath, P. (1986) 
Biochemistry 25, 2403. 
Stochaj, V., Bieseler, B., & Ehring, R. (1 986) Eur. J. Biochem. 
158, 423. 
Teather, R. M., Bramhall, J., Riede, I . ,  Wright, J. K., Fiirst, 
M., Aichele, G., Wilhelm, U., & Overath, P. (1980) Eur. 
J. Biochem. 108, 223. 
Trumble, W. R., Viitanen, P. V., Sarkar, H. K., Poonian, M. 
S. ,  & Kaback, H. R. (1984) Biochem. Biophys. Res. Com- 
mun. 119, 860. 
Vogel, H., Wright, J. K., & Jahnig, F. (1985) EMBO J. 4 ,  
3625. 
Wright, J. K., Dormair, K., Mitaker, S., Moroy, T., Neuhaus, 
J. M., Seckler, R., Vogel, M., Weigel, U., Jahnig, F., & 
Overath, P. (1985) Ann. N.Y.  Acad. Sci. 456, 326. 
Yanish-Perron, C., Vieira, J., & Messing, J. (1985) Gene 33, 
103. 
Zoller, M. J., & Smith, M. (1983) Methods Enzymol. 100, 
468. 
